Other lipid-lowering drugs · Question 46 of 60

Which statements distinguish inclisiran from the PCSK9 antibodies?

2 answers are correct. Hard Created with AI

Show answer

Answer

  • C Inclisiran blocks the production of PCSK9 in the liver cell
  • D After the start phase, inclisiran is injected twice a year

Explanation

Inclisiran is a small RNA (siRNA) that suppresses the production of PCSK9 inside the liver cell. The antibodies, by contrast, capture PCSK9 that has already been released into the blood. Inclisiran is injected at the start, after three months and then every six months, the antibodies every two to four weeks.

Certifications & exams

Which exam comes next?

You can already practise for 51 exams, and 16 are up for a vote. See all certifications with their official information, cast your vote or suggest your exam.

See all certifications